Arlene Weintraub

 Arlene Weintraub
Arlene Weintraub
Contributing Writer

Arlene Weintraub is a science journalist and author with 20 years of experience writing about health care, pharmaceuticals and biotechnology. Her most recent book, Heal: The Vital Role of Dogs in the Search for Cancer Cures (ECW Press 2015), brings to life the world of comparative oncology and the many ways dogs are helping in the war against cancer. Her freelance pieces have been published in the New York Times, US News & World Report, Technology Review, Scientific American, USA Today, and other media outlets. She was previously a senior health writer for BusinessWeek, covering both the science and business of health. She has won awards from the New York Press Club, the Association of Health Care Journalists, the Foundation for Biomedical Research, and the American Society of Business Publication Editors. Her book about the antiaging industry, Selling the Fountain of Youth, was published by Basic Books in 2010.

Stories by Arlene Weintraub

Older dog and cat

BI aims to boost chronic disease portfolio post-Sanofi asset swap

On New Year’s Day, Sanofi and Boehringer Ingelheim closed a $12.5 billion asset swap that had been in the works for a year, giving the closely held Germany-based BI a suite of drugs to treat farm and companion animals. Here's what's next for the company, which had suffered some setbacks on the human side of the business prior to the deal.
Martin Shkreli

UPDATED: Senate proposes incentivizing generic drugmakers

After a yearlong investigation into rising drug prices, the U.S. Senate has released a report that seeks to provide solutions to a tough conundrum: Legislators don’t want the government to intervene in pharmaceutical pricing, but they do want to prevent pharma companies from buying old drugs and then reaping huge profits from them by charging outrageous prices.